Literature DB >> 3193306

Relation of serum erythropoietin levels to renal excretory function: evidence for lowered set point for erythropoietin production in chronic renal failure.

M Chandra1, G K Clemons, M I McVicar.   

Abstract

The relationship of serum erythropoietin (Ep) levels to hematocrit and glomerular (GFR) filtration rate was evaluated in patients with chronic renal disease. The Ep level was measured by radioimmunoassay in 119 blood samples from 48 patients obtained over a period of up to 5 years. Hematocrit values correlated significantly with the GFR, but serum Ep levels did not change with a decline in the GFR. Significant anemia was noted only when the GFR fell below 20 ml/min/1.73 m2. Episodes of spontaneous acute hypoxic stress were observed in six patients with chronic renal failure. Serum Ep levels obtained during these episodes (mean +/- SEM: 273 +/- 76 mU/ml) were tenfold higher than Ep levels during stable steady-state chronic renal failure (26 +/- 6 mU/ml), even though Ep levels were inappropriately low for the degree of anemia in the stable state. Our findings suggest that the tissue oxygenation-Ep-hematocrit feedback mechanism operates at a lower set point in patients with chronic renal failure in comparison with normal subjects.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3193306     DOI: 10.1016/s0022-3476(88)80573-0

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  22 in total

Review 1.  Physiology of the Renal Interstitium.

Authors:  Michael Zeisberg; Raghu Kalluri
Journal:  Clin J Am Soc Nephrol       Date:  2015-03-26       Impact factor: 8.237

2.  Renal clearance of endogenous erythropoietin in patients with proteinuria.

Authors:  M Nowicki; F Kokot; M Kokot; A Bar; J Duława
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

3.  The effect of altitude on dosing and response to erythropoietin in ESRD.

Authors:  M Alan Brookhart; Sebastian Schneeweiss; Jerry Avorn; Brian D Bradbury; Kenneth J Rothman; Michael Fischer; Jyotsna Mehta; Wolfgang C Winkelmayer
Journal:  J Am Soc Nephrol       Date:  2008-04-02       Impact factor: 10.121

Review 4.  HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond.

Authors:  Patrick H Maxwell; Kai-Uwe Eckardt
Journal:  Nat Rev Nephrol       Date:  2015-12-14       Impact factor: 28.314

5.  Anemia and risk of hospitalization in pediatric chronic kidney disease.

Authors:  Amy O Staples; Craig S Wong; Jodi M Smith; Debbie S Gipson; Guido Filler; Bradley A Warady; Karen Martz; Larry A Greenbaum
Journal:  Clin J Am Soc Nephrol       Date:  2008-12-03       Impact factor: 8.237

6.  Urinary obstruction depresses erythropoiesis which recovers after parenchyma-saving surgery but not SWL.

Authors:  Davor Eterović; Marijan Situm; Ante Punda; Vinko Marković; Slaven Kokić
Journal:  Urol Res       Date:  2009-12-01

Review 7.  Erythropoietic stress and anemia in diabetes mellitus.

Authors:  Dhruv K Singh; Peter Winocour; Ken Farrington
Journal:  Nat Rev Endocrinol       Date:  2009-04       Impact factor: 43.330

8.  DNA methyltransferase inhibition restores erythropoietin production in fibrotic murine kidneys.

Authors:  Yu-Ting Chang; Ching-Chin Yang; Szu-Yu Pan; Yu-Hsiang Chou; Fan-Chi Chang; Chun-Fu Lai; Ming-Hsuan Tsai; Huan-Lun Hsu; Ching-Hung Lin; Wen-Chih Chiang; Ming-Shiou Wu; Tzong-Shinn Chu; Yung-Ming Chen; Shuei-Liong Lin
Journal:  J Clin Invest       Date:  2016-01-05       Impact factor: 14.808

9.  Recombinant human erythropoietin therapy in pediatric patients receiving long-term peritoneal dialysis.

Authors:  B A Warady; R J Sabath; C A Smith; U Alon; S Hellerstein
Journal:  Pediatr Nephrol       Date:  1991-11       Impact factor: 3.714

10.  Hemoglobin decline in children with chronic kidney disease: baseline results from the chronic kidney disease in children prospective cohort study.

Authors:  Jeffrey J Fadrowski; Christopher B Pierce; Stephen R Cole; Marva Moxey-Mims; Bradley A Warady; Susan L Furth
Journal:  Clin J Am Soc Nephrol       Date:  2008-01-30       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.